Michael King

Plus aucun poste en cours

Profil

Mr. Michael G.
King, Jr., is a Director of Research & Senior Biotechnology Analyst at Rodman & Renshaw LLC and a Chief Executive Officer at Oqory, Inc. Mr. King was previously employed as a Chief Financial Officer & Executive Vice President by SAB Biotherapeutics, Inc., a Managing Director & Head of Healthcare Research by EF Hutton LLC, a Managing Director & Senior Healthcare Analyst by H.
C.
Wainwright & Co. LLC, a Senior Analyst by JMP Securities LLC, a Managing Director & Senior Analyst by Dawson James Securities, Inc., an Analyst by Rodman & Renshaw LLC (Old), a SVP-Corporate Development & Communication by ZIOPHARM Oncology, Inc., a Managing Director-Equity Research by Wedbush Securities, Inc., a Managing Director by Merriman Curhan Ford & Co., a Senior Analyst by Banc of America Securities LLC, a Senior Analyst by Robertson Stephens, Inc., a Senior Analyst by Vector Securities LLC, a Senior Analyst by Dillon, Read & Co., Inc., a Senior Vice President by Alex.
Brown & Sons, Inc., a Vice President by Hambrecht & Quist LLC, and a Vice President by Kidder, Peabody & Co., Inc. He received his undergraduate degree from Baruch College.

Postes actifs de Michael King

Sociétés	Poste	Début
Rodman & Renshaw LLC	Directeur de la Recherche - Actions	01/01/2026

Anciens postes connus de Michael King

Sociétés	Poste	Fin
SAB BIOTHERAPEUTICS, INC.	Directeur Financier/CFO	04/06/2024
EF Hutton Group	Analyst-Equity	01/05/2023
JMP Securities LLC	Analyst-Equity	06/06/2018
Dawson James Securities, Inc.	Directeur de la Recherche - Actions	31/12/2012
Rodman & Renshaw LLC (Old)	Analyst-Equity	01/09/2012